Exagen Inc.XGNNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P50
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-3.42%
20249.78%
202358.07%
2022-61.06%
2021-55.71%
2020-43.75%
2019-6.46%
201817.64%
20170.00%
2015-11.25%